C Théodore

532 total citations
28 papers, 353 citations indexed

About

C Théodore is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, C Théodore has authored 28 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Pathology and Forensic Medicine. Recurrent topics in C Théodore's work include Testicular diseases and treatments (12 papers), Sarcoma Diagnosis and Treatment (7 papers) and Neuroblastoma Research and Treatments (4 papers). C Théodore is often cited by papers focused on Testicular diseases and treatments (12 papers), Sarcoma Diagnosis and Treatment (7 papers) and Neuroblastoma Research and Treatments (4 papers). C Théodore collaborates with scholars based in France and Italy. C Théodore's co-authors include Karim Fizazi, Stéphane Culine, P. Wibault, Jean‐Pierre Droz, Marie-Josée Terrier-Lacombe, Marie‐José Terrier‐Lacombe, G Benoı̂t, A. Laplanche, Thierry Le Chevalier and Mahasti Saghatchian and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Journal of Hepatology.

In The Last Decade

C Théodore

28 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Théodore France 11 178 134 121 109 81 28 353
Shigeo Nakamura Japan 9 104 0.6× 215 1.6× 71 0.6× 249 2.3× 88 1.1× 12 437
Junji Irie Japan 12 228 1.3× 168 1.3× 159 1.3× 43 0.4× 40 0.5× 46 496
Douglas G. Gold United States 7 137 0.8× 98 0.7× 137 1.1× 71 0.7× 21 0.3× 10 323
Mark Lyda United States 9 112 0.6× 173 1.3× 85 0.7× 137 1.3× 40 0.5× 10 392
Amel Trabelsi Tunisia 13 141 0.8× 148 1.1× 69 0.6× 85 0.8× 19 0.2× 44 410
Dmitry Y. Baschinsky United States 12 193 1.1× 87 0.6× 74 0.6× 97 0.9× 19 0.2× 22 390
Kenji Koda Japan 12 252 1.4× 147 1.1× 158 1.3× 117 1.1× 29 0.4× 55 498
Edi Viale Italy 12 211 1.2× 186 1.4× 157 1.3× 136 1.2× 36 0.4× 36 469
Shinsuke Shibuya Japan 11 101 0.6× 140 1.0× 125 1.0× 31 0.3× 43 0.5× 40 402
Jonathan Rock United States 12 163 0.9× 186 1.4× 47 0.4× 43 0.4× 42 0.5× 15 373

Countries citing papers authored by C Théodore

Since Specialization
Citations

This map shows the geographic impact of C Théodore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Théodore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Théodore more than expected).

Fields of papers citing papers by C Théodore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Théodore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Théodore. The network helps show where C Théodore may publish in the future.

Co-authorship network of co-authors of C Théodore

This figure shows the co-authorship network connecting the top 25 collaborators of C Théodore. A scholar is included among the top collaborators of C Théodore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Théodore. C Théodore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravaud, Alain, Stéphane Oudard, Gwénaëlle Gravis, et al.. (2009). First-line sunitinib in type I and II papillary renal cell carcinoma (PRCC): SUPAP, a phase II study of the French Genito-Urinary Group (GETUG) and the Group of Early Phase trials (GEP). Journal of Clinical Oncology. 27(15_suppl). 5146–5146. 27 indexed citations
2.
Athanasiou, Alexandra, D. Vanel, Omar El Mesbahi, C Théodore, & Karim Fizazi. (2008). Non-germ cell tumours arising in germ cell tumours (teratoma with malignant transformation) in men: CT and MR findings. European Journal of Radiology. 69(2). 230–235. 18 indexed citations
3.
Fléchon, Aude, Stéphane Culine, C Théodore, & J.P. Droz. (2005). Pattern of Relapse after First Line Treatment of Advanced Stage Germ-Cell Tumors. European Urology. 48(6). 957–964. 14 indexed citations
4.
Théodore, C, Marie‐José Terrier‐Lacombe, A. Laplanche, et al.. (2004). Bilateral germ-cell tumours: 22-year experience at the Institut Gustave Roussy. British Journal of Cancer. 90(1). 55–59. 43 indexed citations
5.
Culine, Stéphane, C Théodore, Marco De Santis, et al.. (2003). 844 A phase II study testing intravenous (iv) vinflunine (VFL) as second line therapy in patients with advanced transitional cell cancer (TCC) of the bladder. European Journal of Cancer Supplements. 1(5). S254–S254. 10 indexed citations
6.
Saghatchian, Mahasti, Karim Fizazi, Christian Borel, et al.. (2001). Carcinoma of an unknown primary site: A chemotherapy strategy based on histological differentiation – results of a prospective study. Annals of Oncology. 12(4). 535–540. 32 indexed citations
7.
Avril, M.-F., Agnès Chompret, Marie‐José Terrier‐Lacombe, et al.. (2001). Association between germ cell tumours, large numbers of naevi, atypical naevi and melanoma. Melanoma Research. 11(2). 117–122. 5 indexed citations
8.
Ramaioli, A., C Théodore, M.-J. Terrier-Lacombe, et al.. (2001). Non-Hodgkin’s lymphoma of the testis: A retrospective study of 84 patients treated in the French anticancer centres. Annals of Oncology. 12(9). 1313–1315. 44 indexed citations
9.
Daniel, Catherine, Karim Fizazi, Stéphane Culine, et al.. (2001). Metachronous gonadal and extragonadal primaries, or late relapse of germ cell tumor?. Urologic Oncology Seminars and Original Investigations. 6(2). 49–52. 14 indexed citations
10.
André, Fabrice, Karim Fizazi, Stéphane Culine, et al.. (2000). Peritoneal Carcinomatosis in Germ-Cell Tumor. American Journal of Clinical Oncology. 23(5). 460–462. 4 indexed citations
11.
Culine, Stéphane, et al.. (1997). Evaluation of primary standard cisplatin‐based chemotherapy for clinical stage II non‐seminomatous germ cell tumours of the testis. British Journal of Urology. 79(2). 258–262. 8 indexed citations
12.
Fizazi, Karim, et al.. (1997). [Primary mediastinal non-seminomatous germ-cell tumors: from clinics to biology].. PubMed. 84(3). 313–27. 8 indexed citations
13.
14.
Culine, Stéphane, C Théodore, Marie-Josée Terrier-Lacombe, & Jean‐Pierre Droz. (1996). Primary Chemotherapy in Patients with Nonseminomatous Germ Cell Tumors of the Testis and Biological Disease Only After Orchiectomy. The Journal of Urology. 155(4). 1296–1298. 23 indexed citations
15.
Roithmann, Sérgio, Michel Toledano, J.M. Tourani, et al.. (1991). HIV-associated non-Hodgkin's lymphomas: Clinical characteristics and outcome. The experience of the French Registry of HIV-associated Tumors*. Annals of Oncology. 2(4). 289–295. 39 indexed citations
16.
Rougier, Philippe, Mohamed Azab, M. Henry‐Amar, et al.. (1990). [Primitive digestive localizations of malignant non-Hodgkin's lymphoma. Prognostic factors of locally advanced disease: stage II. Report of 67 cases].. PubMed. 14(8-9). 626–34. 1 indexed citations
17.
Piot, G., Jean‐Pierre Droz, C Théodore, et al.. (1988). Phase II Trial with High-Dose Elliptinium Acetate in Metastatic Renal Cell Carcinoma. Oncology. 45(5). 371–372. 1 indexed citations
18.
Elias, Dominique, et al.. (1987). Early adjuvant intraportal chemotherapy after curative hepatectomy for colorectal liver metastases--a pilot study.. PubMed. 13(3). 247–50. 20 indexed citations
19.
Droz, Jean‐Pierre, Pierre Kerbrat, A. Goodman, et al.. (1985). Phase II trial of elliptinium in advanced renal cell carcinoma.. PubMed. 69(7-8). 901–2. 12 indexed citations
20.
Mf, Avril, et al.. (1984). [Skin manifestations of the Rosai-Dorfman syndrome].. PubMed. 111(8). 661–2. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigeo Nakamura Breakdown of academic impact, for papers by Junji Irie Breakdown of academic impact, for papers by Douglas G. Gold Breakdown of academic impact, for papers by Mark Lyda Breakdown of academic impact, for papers by Amel Trabelsi Breakdown of academic impact, for papers by Dmitry Y. Baschinsky Breakdown of academic impact, for papers by Kenji Koda Breakdown of academic impact, for papers by Edi Viale Breakdown of academic impact, for papers by Shinsuke Shibuya Breakdown of academic impact, for papers by Jonathan Rock
Rankless by CCL
2026